About: covid:PMC7102286

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7102286 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Banerjee, Shubhasree Biehl, Ann Gadina, Massimo Hasni, Sarfaraz Schwartz, Daniella
is schema:about of	named entity 'Current' named entity 'Inflammatory' named entity 'type II IFN' named entity 'phase I trial' named entity 'DAS28' named entity 'cytokines' named entity 'psoriasis' named entity 'ketoconazole' named entity 'autoimmunity' named entity 'Incyte' named entity 'molecule' named entity 'SDAI' named entity 'JAK1' named entity 'sequence conservation' named entity 'baricitinib' named entity 'inducer' named entity 'autoimmune diseases' named entity 'CYP3A4' named entity 'genome-wide association studies' named entity 'monomers' named entity 'STATs' named entity 'chronic mucocutaneous candidiasis' named entity 'serine' named entity 'osmotic' named entity '48 months' named entity 'CYP3A4' named entity 'cytokines' named entity 'intracellular' named entity 'rheumatologic' named entity 'connective tissue' named entity 'efflux pumps' named entity 'sequence conservation' named entity 'CYP3A4' named entity 'allergic' named entity 'JAKs' named entity 'mutation' named entity 'etanercept' named entity 'hematopoietic stem cell transplantation' named entity 'lymphopenia' named entity 'filgotinib' named entity 'DAS28' named entity 'extended release' named entity 'serum' named entity 'JAK1' named entity 'polymorphisms' named entity 'combination therapy' named entity 'IL-4' named entity 'catabolism' named entity 'DMARDs' named entity 'oxidative phosphorylation' named entity 'STAT6' named entity 'Ruxolitinib' named entity 'JAK1' named entity 'long-term' named entity 'ESR' named entity 'synoviocytes' named entity 'methotrexate' named entity 'viral infection' named entity 'regulatory T cells' named entity 'phosphorylated' named entity 'kinetics' named entity 'monotherapy' named entity 'Oligomerization' named entity 'neutropenia' named entity 'DNA-binding' named entity 'EMBASE' named entity 'tetramers' named entity 'CYP3A4' named entity 'plaque psoriasis' named entity 'viral infection' named entity 'Decernotinib' named entity 'tocilizumab' named entity 'myocardial infarction' named entity 'Dominant-negative' named entity 'cytokines' named entity 'polymorphisms' named entity 'patient-reported outcome' named entity 'mycophenolate mofetil' named entity 'binding site' named entity 'isoform' named entity 'JAK3' named entity 'pyruvate kinase' named entity 'tolerability' named entity 'intracellular signaling' named entity 'hormone' named entity 'JAKs' named entity 'creatinine' named entity 'Radixin' named entity 'LOF' named entity 'catalytic site' named entity 'STAT5B' named entity 'IL-17' named entity 'Clinical Trials' named entity 'tofacitinib' named entity 'ruxolitinib'

Attributes

Values

Creator

Banerjee, Shubhasree
Biehl, Ann
Gadina, Massimo
Hasni, Sarfaraz
Schwartz, Daniella

is schema:about of

named entity 'Current'
named entity 'Inflammatory'
named entity 'type II IFN'
named entity 'phase I trial'
named entity 'DAS28'
named entity 'cytokines'
named entity 'psoriasis'
named entity 'ketoconazole'
named entity 'autoimmunity'
named entity 'Incyte'
named entity 'molecule'
named entity 'SDAI'
named entity 'JAK1'
named entity 'sequence conservation'
named entity 'baricitinib'
named entity 'inducer'
named entity 'autoimmune diseases'
named entity 'CYP3A4'
named entity 'genome-wide association studies'
named entity 'monomers'
named entity 'STATs'
named entity 'chronic mucocutaneous candidiasis'
named entity 'serine'
named entity 'osmotic'
named entity '48 months'
named entity 'CYP3A4'
named entity 'cytokines'
named entity 'intracellular'
named entity 'rheumatologic'
named entity 'connective tissue'
named entity 'efflux pumps'
named entity 'sequence conservation'
named entity 'CYP3A4'
named entity 'allergic'
named entity 'JAKs'
named entity 'mutation'
named entity 'etanercept'
named entity 'hematopoietic stem cell transplantation'
named entity 'lymphopenia'
named entity 'filgotinib'
named entity 'DAS28'
named entity 'extended release'
named entity 'serum'
named entity 'JAK1'
named entity 'polymorphisms'
named entity 'combination therapy'
named entity 'IL-4'
named entity 'catabolism'
named entity 'DMARDs'
named entity 'oxidative phosphorylation'
named entity 'STAT6'
named entity 'Ruxolitinib'
named entity 'JAK1'
named entity 'long-term'
named entity 'ESR'
named entity 'synoviocytes'
named entity 'methotrexate'
named entity 'viral infection'
named entity 'regulatory T cells'
named entity 'phosphorylated'
named entity 'kinetics'
named entity 'monotherapy'
named entity 'Oligomerization'
named entity 'neutropenia'
named entity 'DNA-binding'
named entity 'EMBASE'
named entity 'tetramers'
named entity 'CYP3A4'
named entity 'plaque psoriasis'
named entity 'viral infection'
named entity 'Decernotinib'
named entity 'tocilizumab'
named entity 'myocardial infarction'
named entity 'Dominant-negative'
named entity 'cytokines'
named entity 'polymorphisms'
named entity 'patient-reported outcome'
named entity 'mycophenolate mofetil'
named entity 'binding site'
named entity 'isoform'
named entity 'JAK3'
named entity 'pyruvate kinase'
named entity 'tolerability'
named entity 'intracellular signaling'
named entity 'hormone'
named entity 'JAKs'
named entity 'creatinine'
named entity 'Radixin'
named entity 'LOF'
named entity 'catalytic site'
named entity 'STAT5B'
named entity 'IL-17'
named entity 'Clinical Trials'
named entity 'tofacitinib'
named entity 'ruxolitinib'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software